SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-095213
Filing Date
2023-04-07
Accepted
2023-04-07 16:07:07
Documents
21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d466768ddef14a.htm   iXBRL DEF 14A 1033463
6 GRAPHIC g466768dsp20.jpg GRAPHIC 3928
7 GRAPHIC g466768g11i11.jpg GRAPHIC 48717
8 GRAPHIC g466768g22i22.jpg GRAPHIC 53216
9 GRAPHIC g466768g43c81.jpg GRAPHIC 95415
10 GRAPHIC g466768g46m016.jpg GRAPHIC 130560
11 GRAPHIC g466768g46p01.jpg GRAPHIC 47425
12 GRAPHIC g466768g46q017.jpg GRAPHIC 73831
  Complete submission text file 0001193125-23-095213.txt   2765901

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vir-20221231.xsd EX-101.SCH 6310
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vir-20221231_def.xml EX-101.DEF 6727
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20221231_lab.xml EX-101.LAB 10590
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20221231_pre.xml EX-101.PRE 6204
15 EXTRACTED XBRL INSTANCE DOCUMENT d466768ddef14a_htm.xml XML 221107
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39083 | Film No.: 23808842
SIC: 2836 Biological Products, (No Diagnostic Substances)